Background: Multi-drug resistant Escherichia coli has become a major threat and cause of many urinary tract infections (UTIs) in Abeokuta, Nigeria. Objectives: This study was carried out to determine the resistant plasmids of multidrug resistant Escherichia coli isolated from (Urinary tract infections)UTIs in Abeokuta. Methods: A total of 120 Escherichia coli isolates were obtained from urine samples collected from patients attending inpatient and outpatient clinics presenting UTI; with their biodata. Antibiotics susceptibility was performed and multi-drug resistant isolates were selected for plasmid profiling. Plasmids were extracted by the alkaline lysis method, electrophoresed on 0.8% agarose gel and profiled using a gel-photo documentation system gel. Results: Escherichia coli isolates obtained shows high resistance to cloxacillin (92.5%), amoxicillin (90.8%), ampicillin (90.8%), erythromycin (75.8%), cotrimoxazole (70.0%), streptomycin (70.0%) and tetracycline (68.3%) while 85.8% and 84.2% were susceptible to gentamycin and ceftazidime respectively. Sixteen Escherichia coli strains were observed to be resistant to more than two classes of antibiotics. The resistant plasmid DNA was detectable in 6(37.5%) of the 16 multidrug resistant Escherichia coli having single sized plasmids of the same weight 854bp and were all resistant to erythromycin, cefuroxime, cloxacillin, amoxicillin, ampicillin and cotrimoxazole. Conclusion: This study has highlighted the emergence of multidrug resistant R-plasmids among Escherichia coli causing urinary tract infections in Abeokuta, Nigeria. There is a high level of resistance to many antimicrobials that are frequently used in Abeokuta, Nigeria.
Background: Human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) is a major public health problem in sub-saharan Africa. Cytomegalovirus (CMV) has been reported to enhance HIV replication and accelerate the progression of HIV infection to AIDS. Objective: This study reports on the high seropositivity of immunoglobulin (Ig) G and M antibodies against CMV and the risk factors for CMV infection among HIV/AIDS patients in Ilorin, Nigeria. Method: A total of 180 consented HIV-1 seropositive patients (age-range 16-56 years; 108 females and 72 males) were consecutively recruited. Socio-demographic/behavioral data and 5 ml blood samples were collected from each patient. Plasma of each sample was assayed for anti-CMV IgG/IgM using a CMV IgG and IgM Enzyme Linked ImmunoSorbent Assay (ELISA) kit. Results: Twenty (11.1%) of the 180 HIV-1 seropositive subjects were positive for anti-CMV IgM antibody while 169(93.9%) were positive for anti-CMV IgG antibody. Age, marital status, number of sexual partners, CD4 cells counts and previous history of blood transfusion were the main correlates of CMV seropositivity among these patients. However, occupation, sex, highly active antiretroviral therapy (HAART) were not statistically associated with CMV seropositivity in this study. Conclusion:This study has shown that greater percentages of HIV-1 seropositive patients had active CMV infection. It has further shown that CMV is hyperendemic in HIV-1 seropositive patients in Ilorin, Nigeria.
Aims: Continuous increase in the sale and indiscriminate consumption of packaged drinking waters in Nigeria is of public health significance. In order to safe guard public health, it is essential that the available packaged water is of the highest quality. This study was carried out to evaluate the bacteriological quality of packaged water on sale in Owerri metropolis, Imo State of Nigeria. Methodology and Results: From 30 registered sachet water factories, 8 samples each was purchased randomly fifteen of the brands of sachet water all over Owerri metropolis in Imo State, Southeastern Nigeria. These were analyzed for presence of bacterial indicators of water quality. Four weeks later, a second batch of the samples was collected from other brands. A mean plate counts was taken and the organisms from each water sample identified using standard procedures. The results showed that 11 (73.3%) sachet water brands had growths of pathogenic organisms in the first batch while 10 (66.6%) had growth in the second batch. The isolates were identified to be Klebsilla spp., Serratia spp., Proteus spp., Pseudomonas aeruginosa and Chromobacterium spp. The study showed that Klebsiella pneumoniae [7(29.2%)] was the most predominant. This was closely followed by Serratia spp. [6(25.0%)] and Proteus mirabilis [6(25.0%)]. Pseudomonas aeruginosa [3(12.5%)] and Chromobacterium spp. [2(8.3%)] was least predominant. Mean total heterotrophic bacteria plate counts (HPC) per millilitre ranged from 0.0 to 6.0 x 10 2 CFU/mL at 22 °C and 0.0 to 7.0 x 10 2 CFU/mL at 37 °C (first batch) and 0.0 to 5.0 x 10 2 CFU/mL at 22 °C and 0.0 to 10.0 x 10 2 CFU/mL at 37 °C for the second batch. Thus they fell below the United States Environmental Protection Agency (USEPA) and World Health Organization (WHO) drinking water standard of 100 HPC per millilitre of water. Bacteriological examination of different brands of sachet water samples collected from different locations showed that only Vince water and Akudo table water was found to be safe for drinking while the other brands of sachet water from mobile vendors in Owerri metropolis was not potable. Conclusion, Significance and Impact of study: Hence, the bacteriological quality of some of the brands of sachet water on sale in Owerri was of poor quality index. The study suggests that sachet water could be a route of transmission of enteric pathogens among the populace. In order to safe guard public health, highest quality brands of sachet water is therefore advocated.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.